Linqi Zhang

InstitutionAffiliated Cancer Hospital&Institute of Guangzhou Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 3 publications in March 2021
    All Publications
    Bar chart showing 136 publications over 20 distinct years, with a maximum of 13 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang Q, Ju B, Ge J, Chan JF, Cheng L, Wang R, Huang W, Fang M, Chen P, Zhou B, Song S, Shan S, Yan B, Zhang S, Ge X, Yu J, Zhao J, Wang H, Liu L, Lv Q, Fu L, Shi X, Yuen KY, Liu L, Wang Y, Chen Z, Zhang L, Wang X, Zhang Z. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210. PMID: 34244522.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    2. Hu Y, Guo J, Li G, Lu X, Li X, Zhang Y, Cong L, Kang Y, Jia X, Shi X, Xie G, Zhang L. Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study. BMJ Open. 2021 07 07; 11(7):e045886. PMID: 34233974.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Li M, Guo J, Lu S, Zhou R, Shi H, Shi X, Cheng L, Liang Q, Liu H, Wang P, Wang N, Wang Y, Fu L, Xing M, Wang R, Ju B, Liu L, Lau SY, Jia W, Tong X, Yuan L, Guo Y, Qi H, Zhang Q, Huang Z, Chen H, Zhang Z, Chen Z, Peng X, Zhou D, Zhang L. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Front Immunol. 2021; 12:697074. PMID: 34262569.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    4. Wang R, Zhang Q, Ge J, Ren W, Zhang R, Lan J, Ju B, Su B, Yu F, Chen P, Liao H, Feng Y, Li X, Shi X, Zhang Z, Zhang F, Ding Q, Zhang T, Wang X, Zhang L. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021 07 13; 54(7):1611-1621.e5. PMID: 34166623.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    5. Liu X, Xu X, Li G, Xu X, Sun Y, Wang F, Shi X, Li X, Xie G, Zhang L. Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States. BMC Public Health. 2021 05 21; 21(1):965. PMID: 34020613.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    6. Chen T, Huang S, Li G, Zhang Y, Li Y, Zhu J, Shi X, Li X, Xie G, Zhang L. An integrated framework for modelling quantitative effects of entry restrictions and travel quarantine on importation risk of COVID-19. J Biomed Inform. 2021 06; 118:103800. PMID: 33965636.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Yan R, Wang R, Ju B, Yu J, Zhang Y, Liu N, Wang J, Zhang Q, Chen P, Zhou B, Li Y, Shen Y, Zhang S, Tian L, Guo Y, Xia L, Zhong X, Cheng L, Ge X, Zhao J, Wang HW, Wang X, Zhang Z, Zhang L, Zhou Q. Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. 2021 05; 31(5):517-525. PMID: 33731853.
      Citations: 10     Fields:    Translation:HumansCells
    8. Ju X, Zhu Y, Wang Y, Li J, Zhang J, Gong M, Ren W, Li S, Zhong J, Zhang L, Zhang QC, Zhang R, Ding Q. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog. 2021 03; 17(3):e1009439. PMID: 33711082.
      Citations: 14     Fields:    Translation:Humans
    9. Zhang S, Qiao S, Yu J, Zeng J, Shan S, Tian L, Lan J, Zhang L, Wang X. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat Commun. 2021 03 11; 12(1):1607. PMID: 33707453.
      Citations: 13     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Zhou D, Chan JF, Zhou B, Zhou R, Li S, Shan S, Liu L, Zhang AJ, Chen SJ, Chan CC, Xu H, Poon VK, Yuan S, Li C, Chik KK, Chan CC, Cao J, Chan CY, Kwan KY, Du Z, Lau TT, Zhang Q, Zhou J, To KK, Zhang L, Ho DD, Yuen KY, Chen Z. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host Microbe. 2021 04 14; 29(4):551-563.e5. PMID: 33657424.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    11. Li Q, Nie J, Wu J, Zhang L, Ding R, Wang H, Zhang Y, Li T, Liu S, Zhang M, Zhao C, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Liu J, Liang H, Shi Y, Shen Y, Xie L, Zhang L, Qu X, Xu W, Huang W, Wang Y. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9. PMID: 33735608.
      Citations: 67     Fields:    Translation:HumansCells
    12. Ge J, Wang R, Ju B, Zhang Q, Sun J, Chen P, Zhang S, Tian Y, Shan S, Cheng L, Zhou B, Song S, Zhao J, Wang H, Shi X, Ding Q, Liu L, Zhao J, Zhang Z, Wang X, Zhang L. Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry. Nat Commun. 2021 01 11; 12(1):250. PMID: 33431856.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    13. Ge J, Zhang S, Zhang L, Wang X. Structural basis of severe acute respiratory syndrome coronavirus 2 infection. Curr Opin HIV AIDS. 2021 01; 16(1):74-81. PMID: 33186231.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    14. Li H, Zhao C, Zhang Y, Yuan F, Zhang Q, Shi X, Zhang L, Qin C, Zheng A. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays. Emerg Microbes Infect. 2020 Dec; 9(1):2269-2277. PMID: 32990161.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    15. Cao Y, Wu H, Zhai W, Wang Y, Li M, Li M, Yang L, Tian Y, Song Y, Li J, Wang Y, Ding Q, Zhang L, Cai M, Chang Z. A safety consideration of mesenchymal stem cell therapy on COVID-19. Stem Cell Res. 2020 12; 49:102066. PMID: 33242791.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    16. Li G, Zhou Y, Ji J, Liu X, Jin Q, Zhang L. Surging publications on the COVID-19 pandemic. Clin Microbiol Infect. 2021 Mar; 27(3):484-486. PMID: 32977004.
      Citations: 1     Fields:    Translation:Humans
    17. Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA. 2020 08 04; 324(5):460-470. PMID: 32492084.
      Citations: 447     Fields:    Translation:HumansCellsPHPublic Health
    18. Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, Zhao C, Zhang Q, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Sun Q, Liu J, Zhang L, Li X, Huang W, Wang Y. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9. PMID: 32730807.
      Citations: 429     Fields:    Translation:HumansAnimalsCells
    19. Li G, Yin C, Zhou Y, Wang T, Chen J, Liu Y, Chen T, Wang H, Zhang L, Chen X. Digitalized Adaptation of Oncology Trials during and after COVID-19. Cancer Cell. 2020 08 10; 38(2):148-149. PMID: 32634378.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    20. Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, Tang X, Yu J, Lan J, Yuan J, Wang H, Zhao J, Zhang S, Wang Y, Shi X, Liu L, Zhao J, Wang X, Zhang Z, Zhang L. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020 08; 584(7819):115-119. PMID: 32454513.
      Citations: 585     Fields:    Translation:HumansCellsPHPublic Health
    21. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020 05; 581(7807):215-220. PMID: 32225176.
      Citations: 1479     Fields:    Translation:HumansCells
    22. Zhou H, Chen Y, Zhang S, Niu P, Qin K, Jia W, Huang B, Zhang S, Lan J, Zhang L, Tan W, Wang X. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat Commun. 2019 07 11; 10(1):3068. PMID: 31296843.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    23. Jia W, Channappanavar R, Zhang C, Li M, Zhou H, Zhang S, Zhou P, Xu J, Shan S, Shi X, Wang X, Zhao J, Zhou D, Perlman S, Zhang L. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerg Microbes Infect. 2019; 8(1):760-772. PMID: 31130102.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    24. Xu J, Jia W, Wang P, Zhang S, Shi X, Wang X, Zhang L. Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2019; 8(1):841-856. PMID: 31169078.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    25. Niu P, Zhang S, Zhou P, Huang B, Deng Y, Qin K, Wang P, Wang W, Wang X, Zhou J, Zhang L, Tan W. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260. PMID: 29846635.
      Citations: 22     Fields:    Translation:HumansCells
    26. Zhang S, Zhou P, Wang P, Li Y, Jiang L, Jia W, Wang H, Fan A, Wang D, Shi X, Fang X, Hammel M, Wang S, Wang X, Zhang L. Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein. Cell Rep. 2018 07 10; 24(2):441-452. PMID: 29996104.
      Citations: 25     Fields:    Translation:HumansCells
    27. Dimitrov DS, Jiang S, Ying T, Tseng CT, Zhang L, Yuen KY. No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. Proc Natl Acad Sci U S A. 2015 Sep 15; 112(37):E5115. PMID: 26318165.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    28. Yu X, Zhang S, Jiang L, Cui Y, Li D, Wang D, Wang N, Fu L, Shi X, Li Z, Zhang L, Wang X. Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27. Sci Rep. 2015 Aug 18; 5:13133. PMID: 26281793.
      Citations: 32     Fields:    Translation:HumansCells
    29. Jiang L, Wang N, Zuo T, Shi X, Poon KM, Wu Y, Gao F, Li D, Wang R, Guo J, Fu L, Yuen KY, Zheng BJ, Wang X, Zhang L. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med. 2014 Apr 30; 6(234):234ra59. PMID: 24778414.
      Citations: 99     Fields:    Translation:HumansCells
    30. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, Guo D, Fu L, Cui Y, Liu X, Arledge KC, Chen YH, Zhang L, Wang X. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013 Aug; 23(8):986-93. PMID: 23835475.
      Citations: 278     Fields:    Translation:HumansAnimalsCells
    31. Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H, Jiang H, Zhou J, Lam P, Zhang L, Lackner A, Qin C, Chen Z. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011 Apr; 85(8):4025-30. PMID: 21289121.
      Citations: 132     Fields:    Translation:AnimalsCells
    32. Huang X, Lu B, Yu W, Fang Q, Liu L, Zhuang K, Shen T, Wang H, Tian P, Zhang L, Chen Z. A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. PLoS One. 2009; 4(1):e4180. PMID: 19159014.
      Citations: 22     Fields:    Translation:AnimalsCellsPHPublic Health
    33. Bian C, Zhang X, Cai X, Zhang L, Chen Z, Zha Y, Xu Y, Xu K, Lu W, Yan L, Yuan J, Feng J, Hao P, Wang Q, Zhao G, Liu G, Zhu X, Shen H, Zheng B, Shen B, Sun B. Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody. Virology. 2009 Jan 05; 383(1):39-46. PMID: 18986662.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    34. Ba L, Yi CE, Zhang L, Ho DD, Chen Z. Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. Appl Microbiol Biotechnol. 2007 Oct; 76(5):1131-6. PMID: 17581748.
      Citations: 7     Fields:    Translation:AnimalsCellsPHPublic Health
    35. Liu L, Fang Q, Deng F, Wang H, Yi CE, Ba L, Yu W, Lin RD, Li T, Hu Z, Ho DD, Zhang L, Chen Z. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol. 2007 May; 81(9):4694-700. PMID: 17314167.
      Citations: 29     Fields:    Translation:Cells
    36. Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, Han Y, Xu W, Zhang W, You H, Zuo Y, Fang Q, Yu J, Chen Z, Zhang L. Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One. 2006 Dec 20; 1:e24. PMID: 17183651.
      Citations: 33     Fields:    Translation:HumansCells
    37. Zhang L, Zhang F, Yu W, He T, Yu J, Yi CE, Ba L, Li W, Farzan M, Chen Z, Yuen KY, Ho D. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006 Jan; 78(1):1-8. PMID: 16299724.
      Citations: 95     Fields:    Translation:HumansCells
    38. Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68. PMID: 15993989.
      Citations: 25     Fields:    Translation:AnimalsCells
    39. Yi CE, Ba L, Zhang L, Ho DD, Chen Z. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J Virol. 2005 Sep; 79(18):11638-46. PMID: 16140741.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    40. Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88. PMID: 15708987.
      Citations: 103     Fields:    Translation:AnimalsCells
    41. Kao RY, Tsui WH, Lee TS, Tanner JA, Watt RM, Huang JD, Hu L, Chen G, Chen Z, Zhang L, He T, Chan KH, Tse H, To AP, Ng LW, Wong BC, Tsoi HW, Yang D, Ho DD, Yuen KY. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol. 2004 Sep; 11(9):1293-9. PMID: 15380189.
      Citations: 76     Fields:    Translation:AnimalsCells
    Zhang's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (284)
    Explore
    _
    Co-Authors (320)
    Explore
    _
    Similar People (60)
    Explore
    _